vs

Side-by-side financial comparison of MEDIFAST INC (MED) and PAMT CORP (PAMT). Click either name above to swap in a different company.

PAMT CORP is the larger business by last-quarter revenue ($141.3M vs $75.1M, roughly 1.9× MEDIFAST INC). On growth, PAMT CORP posted the faster year-over-year revenue change (-15.1% vs -36.9%). MEDIFAST INC produced more free cash flow last quarter ($-6.6M vs $-25.0M). Over the past eight quarters, PAMT CORP's revenue compounded faster (-12.0% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

MED vs PAMT — Head-to-Head

Bigger by revenue
PAMT
PAMT
1.9× larger
PAMT
$141.3M
$75.1M
MED
Growing faster (revenue YoY)
PAMT
PAMT
+21.8% gap
PAMT
-15.1%
-36.9%
MED
More free cash flow
MED
MED
$18.3M more FCF
MED
$-6.6M
$-25.0M
PAMT
Faster 2-yr revenue CAGR
PAMT
PAMT
Annualised
PAMT
-12.0%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
PAMT
PAMT
Revenue
$75.1M
$141.3M
Net Profit
$-29.3M
Gross Margin
69.4%
Operating Margin
-10.4%
-27.0%
Net Margin
-20.7%
Revenue YoY
-36.9%
-15.1%
Net Profit YoY
7.4%
EPS (diluted)
$-1.64
$-1.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
PAMT
PAMT
Q4 25
$75.1M
$141.3M
Q3 25
$89.4M
$150.3M
Q2 25
$105.6M
$151.1M
Q1 25
$115.7M
$155.3M
Q4 24
$119.0M
$166.5M
Q3 24
$140.2M
$182.6M
Q2 24
$168.6M
$182.9M
Q1 24
$174.7M
$182.6M
Net Profit
MED
MED
PAMT
PAMT
Q4 25
$-29.3M
Q3 25
$-2.3M
$-5.6M
Q2 25
$2.5M
$-9.6M
Q1 25
$-772.0K
$-8.1M
Q4 24
$-31.6M
Q3 24
$1.1M
$2.4M
Q2 24
$-8.2M
$-2.9M
Q1 24
$8.3M
$281.0K
Gross Margin
MED
MED
PAMT
PAMT
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
PAMT
PAMT
Q4 25
-10.4%
-27.0%
Q3 25
-4.6%
-3.8%
Q2 25
-1.0%
-7.3%
Q1 25
-1.1%
-5.9%
Q4 24
0.6%
-22.6%
Q3 24
1.5%
1.3%
Q2 24
-4.7%
-0.4%
Q1 24
4.5%
-0.4%
Net Margin
MED
MED
PAMT
PAMT
Q4 25
-20.7%
Q3 25
-2.5%
-3.7%
Q2 25
2.3%
-6.4%
Q1 25
-0.7%
-5.2%
Q4 24
-19.0%
Q3 24
0.8%
1.3%
Q2 24
-4.8%
-1.6%
Q1 24
4.8%
0.2%
EPS (diluted)
MED
MED
PAMT
PAMT
Q4 25
$-1.64
$-1.38
Q3 25
$-0.21
$-0.27
Q2 25
$0.22
$-0.46
Q1 25
$-0.07
$-0.37
Q4 24
$0.08
$-1.44
Q3 24
$0.10
$0.11
Q2 24
$-0.75
$-0.13
Q1 24
$0.76
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
PAMT
PAMT
Cash + ST InvestmentsLiquidity on hand
$167.3M
$83.7M
Total DebtLower is stronger
$333.9M
Stockholders' EquityBook value
$198.9M
$210.5M
Total Assets
$248.0M
$697.9M
Debt / EquityLower = less leverage
1.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
PAMT
PAMT
Q4 25
$167.3M
$83.7M
Q3 25
$173.5M
$115.6M
Q2 25
$162.7M
$117.3M
Q1 25
$164.6M
$102.7M
Q4 24
$162.3M
$110.7M
Q3 24
$170.0M
$92.3M
Q2 24
$163.5M
$114.0M
Q1 24
$156.4M
$125.8M
Total Debt
MED
MED
PAMT
PAMT
Q4 25
$333.9M
Q3 25
Q2 25
Q1 25
Q4 24
$325.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MED
MED
PAMT
PAMT
Q4 25
$198.9M
$210.5M
Q3 25
$214.7M
$239.5M
Q2 25
$216.0M
$244.9M
Q1 25
$211.0M
$269.6M
Q4 24
$210.1M
$277.5M
Q3 24
$207.3M
$308.9M
Q2 24
$205.3M
$306.7M
Q1 24
$211.0M
$314.6M
Total Assets
MED
MED
PAMT
PAMT
Q4 25
$248.0M
$697.9M
Q3 25
$268.2M
$715.2M
Q2 25
$269.3M
$707.9M
Q1 25
$280.0M
$712.6M
Q4 24
$284.2M
$741.7M
Q3 24
$291.2M
$756.7M
Q2 24
$293.5M
$733.5M
Q1 24
$302.8M
$746.4M
Debt / Equity
MED
MED
PAMT
PAMT
Q4 25
1.59×
Q3 25
Q2 25
Q1 25
Q4 24
1.17×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
PAMT
PAMT
Operating Cash FlowLast quarter
$-5.3M
$-5.8M
Free Cash FlowOCF − Capex
$-6.6M
$-25.0M
FCF MarginFCF / Revenue
-8.8%
-17.7%
Capex IntensityCapex / Revenue
1.8%
13.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$-23.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
PAMT
PAMT
Q4 25
$-5.3M
$-5.8M
Q3 25
$12.1M
$5.9M
Q2 25
$-3.4M
$12.2M
Q1 25
$3.4M
$5.0M
Q4 24
$-4.9M
$15.2M
Q3 24
$9.1M
$15.5M
Q2 24
$13.1M
$18.7M
Q1 24
$7.3M
$9.6M
Free Cash Flow
MED
MED
PAMT
PAMT
Q4 25
$-6.6M
$-25.0M
Q3 25
$10.8M
$2.5M
Q2 25
$-4.8M
$5.9M
Q1 25
$1.9M
$-6.8M
Q4 24
$-7.2M
$-39.9M
Q3 24
$7.7M
$-33.6M
Q2 24
$11.1M
$4.1M
Q1 24
$5.4M
$-12.2M
FCF Margin
MED
MED
PAMT
PAMT
Q4 25
-8.8%
-17.7%
Q3 25
12.0%
1.7%
Q2 25
-4.5%
3.9%
Q1 25
1.6%
-4.4%
Q4 24
-6.1%
-24.0%
Q3 24
5.5%
-18.4%
Q2 24
6.6%
2.2%
Q1 24
3.1%
-6.7%
Capex Intensity
MED
MED
PAMT
PAMT
Q4 25
1.8%
13.6%
Q3 25
1.5%
2.3%
Q2 25
1.3%
4.2%
Q1 25
1.3%
7.6%
Q4 24
1.9%
33.1%
Q3 24
1.0%
26.9%
Q2 24
1.1%
8.0%
Q1 24
1.1%
12.0%
Cash Conversion
MED
MED
PAMT
PAMT
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
6.44×
Q2 24
Q1 24
0.88×
34.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

PAMT
PAMT

Freight Transportation Service$123.1M87%
Fuel Surcharge$18.2M13%

Related Comparisons